PROK News

Latest breaking news and updates for PROK stock.

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

WINSTON-SALEM, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chroni...

Conference

11 days ago

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

WINSTON-SALEM, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cell therapeutics company focused on chronic ki...

How might the disclosed regulatory timeline affect the timing of potential product commercialization and revenue generation? What are the potential risks highlighted in the regulatory and clinical updates (e.g., trial enrollment challenges, safety concerns)? Did the company announce any partnership, licensing, or financing agreements in the quarter that could impact valuation?

Earnings

26 days ago